Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Collaborate
About
EQOH
Careers
Contact Us
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
CME
search
Join
FREE
This site is intended for healthcare professionals
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Collaborate
About
EQOH
Careers
Contact Us
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
CME
Join
FREE
Edition
European
US
Dermatology
Filter
Journals
About
Congress reviews
Abstracts
Articles
Podcasts
Videos & Webinars
News
Infographics
Submit A Paper
Hidradenitis Suppurativa Patient-Reported Outcome Measures Reviewed
January 2026
A review found seven hidradenitis suppurativa patient-reported key outcome measures, with HiSQOL-17 performing best across studies.
Read more
29 Jan 2026
Hidradenitis Suppurativa Patient-Reported Outcome Measures Reviewed
A review found seven hidradenitis suppurativa patient-reported key outcome measures, with HiSQOL-17 performing best across studies.
26 Jan 2026
Risankizumab Shows Deep Skin Response in Psoriasis
Risankizumab delivered sustained psoriasis clearance and reduced subclinical inflammation on OCT imaging across 52 weeks follow-up.
19 Jan 2026
Registry Data Show Apremilast Benefits in Psoriasis
Real-world PsoBest data show apremilast improved psoriasis severity, involvement, and quality of life over 12 months in usual care.
15 Jan 2026
Treating Stretch Marks with Combination Care
An overview highlights combination strategies that improve stretch marks through Fitzpatrick phototypes in practice for clinicians.
8 Jan 2026
Tildrakizumab Shows Real World Gains in Plaque Psoriasis
Real-world meta-analysis found tildrakizumab substantially improved plaque psoriasis severity and quality of life through 52 weeks.
5 Jan 2026
Indoor Tanning Behaves Like Smoking for Skin
Indoor tanning bed use substantially raises melanoma, BCC, and cSCC risks, underscoring this well-established carcinogenic profile.
1 Jan 2026
Tinea Capitis Outcomes Worsen with Nutrient Deficiencies
In children, deficiencies in zinc and vitamin D independently increased tinea capitis risk and lowered 8-week clinical cure rates.
29 Dec 2025
Hidradenitis Suppurativa Biologics Show Early Differences
Bimekizumab showed the strongest short-term efficacy among hidradenitis suppurativa biologics in trials assessed at Week 12 to 16.
Loading posts...
1
2
3
…
21
Next »
We’ve noticed you’re accessing
from
North/South America.
View
View